Skip to Main Content

Paper Details

Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
Circulation
5
2023
Author NameAffiliation
Rahul AggarwalRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center (R.A., Harvard Medical School
Rahul AggarwalHarvard Medical School
Daniel E SingerMassachusetts General Hospital (D.E.S.), Harvard Medical School
Eric A SecemskyRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center (R.A., Harvard Medical School
Jonathan P PicciniDuke Clinical Research Institute, Duke University
Robert W YehRichard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center (R.A., Harvard Medical School
  • 1 - 6

Datasets